Epidemiology Practice Questions

Q: Which of the following statements is NOT true about a point source epidemic?

Plateau phase. ***Plateau phase*** (Correct Answer - This is NOT true) - A **plateau phase** is characterized by a sustained period of high incidence, which is typical of a **propagated epidemic** where transmission continues over time, **not a point source epidemic**. - In a point source epidemic, due to a single, brief exposure, the number of cases rises sharply and then falls quickly, typically **without a prolonged plateau**. - Point source epidemics show a **sharp rise and rapid fall**, reflecting the fact that all exposures occurred at approximately the same time. *Explosive epidemic* (True statement - not the answer) - This statement is **true** for a point source epidemic, as exposure to the common source often leads to a rapid increase in the number of cases over a short period. - The epidemic curve typically rises sharply and falls quickly, reflecting the **simultaneous exposure** of a large number of susceptible individuals. *Only one peak* (True statement - not the answer) - This statement is **true** for a point source epidemic, as all cases generally occur within one **incubation period** following a single common exposure, resulting in a single, distinct peak in the epidemic curve. - The single peak differentiates it from propagated epidemics, which can have multiple peaks reflecting successive generations of infection. *No secondary waves* (True statement - not the answer) - This statement is **true** for a point source epidemic because everyone exposed to the common source at the same time is infected, and there's no ongoing person-to-person transmission to create subsequent waves. - The epidemic curve will show cases occurring within one **incubation period** following the single exposure.

Q: In a village with a population of 10,000, where 250 individuals suffered from malaria, of whom 50 died, and another 100 individuals suffered from dengue, of whom 30 died in 2013, what is the case fatality rate of dengue?

30. ***Correct Option: 30*** - The **case fatality rate (CFR)** is calculated as the number of deaths from a specific disease divided by the total number of confirmed cases of that disease, multiplied by 100 to express it as a percentage. - Formula: CFR = (Number of deaths from disease / Number of cases of disease) × 100 - For dengue in this scenario: CFR = (30 deaths / 100 cases) × 100 = **30%** - This indicates that 30% of individuals diagnosed with dengue in this village died from the disease, which represents a high case fatality rate for dengue. *Incorrect Option: 80* - This value does not correspond to any standard epidemiological calculation for dengue in this scenario. - It might represent a miscalculation or confusion with other epidemiological rates. - The total deaths from both diseases (30 + 50 = 80) should not be confused with the CFR of dengue alone. *Incorrect Option: 70* - This figure is not derived from the correct CFR calculation for dengue. - It does not represent any meaningful epidemiological measure from the given data. - May result from incorrectly adding cases and deaths or other computational errors. *Incorrect Option: 40* - This value is incorrect for the dengue CFR calculation. - It does not align with the formula: (30/100) × 100 = 30%, not 40%. - This might result from misreading the data or applying an incorrect calculation method.

Q: The comparison of mortality rates between two countries requires the application of direct standardization. Which of the following parameters makes it necessary to have standardization?

Age distributions. ***Age distributions*** - **Direct standardization** is crucial when comparing mortality rates between populations with different **age structures**. A population with a larger proportion of older individuals will naturally have a higher crude mortality rate regardless of underlying health. - By standardizing for age, we can remove the confounding effect of age and get a more accurate comparison of **disease burden** or **healthcare effectiveness**. *Numerators* - The numerator in mortality rates typically represents the **number of deaths**, which is a direct count and does not inherently require standardization to be understood. - While the numerator is essential for calculating the rate, its raw value doesn't introduce bias in comparison as much as population characteristics. *Denominators* - The denominator represents the **total population at risk**, which is used in calculating crude mortality rates. - While vital for rate calculation, the denominator itself doesn't directly cause a need for standardization; rather, the **composition** of the denominator (e.g., age groups) is the critical factor. *Causes of death* - While comparing **specific causes of death** can be informative, the "cause of death" itself does not necessitate overall mortality rate standardization. - Standardization focuses on population characteristics (like age) that influence the overall likelihood of death, not the specific etiology.

Q: Consistency of a screening test depends on

Reliability. ***Reliability*** - The **consistency** of a screening test refers to its ability to produce the same results when repeated under the same conditions. This characteristic is known as **reliability** or reproducibility. - A reliable test minimizes **random error**, ensuring that variations in results are due to actual changes in the individual rather than testing inaccuracies. *Accuracy (overall correctness of the test)* - **Accuracy** refers to how close a test result is to the **true value**, which is a measure of validity, not solely consistency. - A test can be reliable (consistent) but not accurate, meaning it consistently produces the same incorrect results. *Sensitivity (correctly identifies those with the disease)* - **Sensitivity** is the proportion of true positives that are correctly identified by the test, indicating its ability to correctly identify individuals *with* the disease. - This is a measure of the test's **validity** in detecting disease, not its consistency over repeated measurements. *Specificity (correctly identifies those without the disease)* - **Specificity** is the proportion of true negatives that are correctly identified by the test, indicating its ability to correctly identify individuals *without* the disease. - This is also a measure of the test's **validity** in ruling out disease, rather than its consistency when repeated.

Q: As per WHO guidelines, iodine deficiency disorders are considered endemic in the community when the prevalence of goitre in school-age children exceeds what percentage?

5%. ***5%*** - According to **WHO guidelines**, iodine deficiency disorders are considered **endemic** when the prevalence of goitre in school-age children **exceeds 5%**. - This is the **specific threshold** established by WHO to classify a community as having endemic iodine deficiency requiring public health intervention. - School-age children (6-12 years) are used as the indicator population because they are the most sensitive group for detecting iodine deficiency. *1%* - This percentage is **below the WHO threshold** of 5% for defining endemic iodine deficiency. - A prevalence of 1% indicates mild iodine insufficiency but does not meet the criteria for endemicity requiring immediate widespread intervention. *10%* - While 10% prevalence certainly indicates a **moderate to severe public health problem**, this is not the WHO threshold for defining endemicity. - The threshold is **5%, not 10%** - any prevalence exceeding 5% (including 10%) would be classified as endemic. *15%* - This represents a **severe iodine deficiency problem**, but it is not the WHO threshold percentage. - The correct threshold is **5%** - both 10% and 15% exceed this threshold and would be classified as endemic, but they are not the defining cutoff point.

Q: Specificity of a diagnostic test is defined as:

0.95. ***0.95*** - **Specificity** is the proportion of individuals without disease who test negative, calculated as **TN/(TN+FP)**. - A specificity of 0.95 (95%) indicates an excellent test that correctly identifies 95% of healthy individuals as negative. *0.05* - This value represents the **false positive rate** (1 - specificity), not specificity itself. - A specificity of 0.05 would mean only 5% of healthy individuals test negative, indicating a very poor test. *0.4* - This value is too low for specificity and could represent other test parameters like **positive predictive value**. - A specificity of 0.4 would incorrectly classify 60% of healthy individuals as positive, making the test clinically unreliable. *0.8* - This value typically represents **sensitivity**, which is the proportion of diseased individuals who test positive. - **Sensitivity** is calculated as **TP/(TP+FN)**, which is different from specificity that focuses on healthy individuals.

Q: Attributable risk refers to which of the following?

Risk difference between exposed and unexposed populations.. ***Risk difference between exposed and unexposed populations.*** - **Attributable risk (AR)**, also known as **risk difference**, quantifies the absolute difference in disease incidence (or risk) between an exposed group and an unexposed group. - It represents the amount of disease risk that can be directly attributed to the exposure, which could theoretically be prevented if the exposure were eliminated. - Formula: AR = Incidence in exposed - Incidence in unexposed *Fatality of a disease.* - The **fatality of a disease** is measured by the **case fatality rate (CFR)**, which indicates the proportion of individuals diagnosed with a disease who die from it. - This is a measure of disease severity, not the incremental risk due to an exposure. *Disease risk ratio between exposed and non-exposed.* - The **disease risk ratio** (or **relative risk, RR**) compares the incidence of disease in an exposed group to the incidence in an unexposed group as a ratio. - Formula: RR = (Incidence in exposed) / (Incidence in unexposed) - While it measures the strength of association, it does not represent the absolute amount of risk attributable to the exposure. *Communicability of a disease.* - The **communicability of a disease** refers to its ability to spread from one individual to another, often measured by metrics like the **basic reproduction number (R₀)**. - This concept is related to infectious disease transmission dynamics, not the attributable risk of a specific exposure.

Q: Which of the following is the primary epidemiological indicator for malaria?

Annual parasite incidence. ***Annual parasite incidence*** - **Annual parasite incidence (API)** refers to the number of confirmed malaria cases per 1,000 population per year in a given area. - It is a **key epidemiological indicator** used to assess the burden of malaria and track trends over time, providing a direct measure of disease occurrence. *Annual falciparum incidence* - This indicator focuses specifically on **_Plasmodium falciparum_ infections**, which are often the most severe form of malaria. - While important, it does not encompass all malaria species and therefore provides a less comprehensive measure of the overall malaria burden compared to API. *Annual blood examination rate* - The **annual blood examination rate (ABER)** indicates the number of blood slides examined for malaria per 1,000 population per year. - It is a measure of **surveillance effort** and access to diagnostic testing, rather than a direct measure of malaria incidence. *Annual incidence of malaria cases* - While this phrase describes generally what an epidemiological indicator for malaria would measure, it is less specific and a less commonly used standardized term than **Annual Parasite Incidence (API)**. - The term **API** is universally recognized and has a precise definition related to confirmed parasite-positive cases per 1,000 population.

Q: What is the secondary attack rate in a household with 9 susceptible individuals, where 1 individual becomes infected initially and 2 additional individuals become infected 2 days later?

25%. ***25%*** - The secondary attack rate is calculated as **(Number of secondary cases / Total number of susceptible contacts) * 100**. - In this scenario, there are 2 new cases among 8 susceptible contacts (initially 9 susceptible, minus the 1 primary case). So, (2 / 8) * 100 = **25%**. *33%* - This percentage would be relevant if there were 2 secondary cases out of 6 susceptible individuals, which is not the case here. - This calculation misrepresents the denominator by not correctly accounting for the initial prevalent case. *50%* - This would imply 2 secondary cases out of 4 susceptible individuals, which is not consistent with the given problem. - It would overestimate the secondary attack rate based on the provided numbers. *65%* - This percentage is significantly higher than what the given data suggests for the secondary attack rate. - It does not correspond to the calculation of 2 secondary cases among 8 susceptible individuals.

Question 1

Which of the following statements is NOT true about a point source epidemic?

Accepted Answer

Plateau phase

Answer

Explosive epidemic

Answer

Only one peak

Answer

No secondary waves

Question 2

In a village with a population of 10,000, where 250 individuals suffered from malaria, of whom 50 died, and another 100 individuals suffered from dengue, of whom 30 died in 2013, what is the case fatality rate of dengue?

Accepted Answer

30

Answer

80

Answer

70

Answer

40

Question 3

The comparison of mortality rates between two countries requires the application of direct standardization. Which of the following parameters makes it necessary to have standardization?

Accepted Answer

Age distributions

Answer

Numerators

Answer

Denominators

Answer

Causes of death

Question 4

Consistency of a screening test depends on

Accepted Answer

Reliability

Answer

Accuracy (overall correctness of the test)

Answer

Sensitivity (correctly identifies those with the disease)

Answer

Specificity (correctly identifies those without the disease)

Question 5

What does endemic disease mean?

Accepted Answer

Is consistently present in a specific population or geographic area

Answer

Occurs clearly in excess of normal expectancy

Answer

Exhibits seasonal pattern

Answer

Is prevalent among animals

Question 6

As per WHO guidelines, iodine deficiency disorders are considered endemic in the community when the prevalence of goitre in school-age children exceeds what percentage?

Accepted Answer

5%

Answer

10%

Answer

15%

Answer

1%

Question 7

Specificity of a diagnostic test is defined as:

Accepted Answer

0.95

Answer

0.05

Answer

0.4

Answer

0.8

Question 8

Attributable risk refers to which of the following?

Accepted Answer

Risk difference between exposed and unexposed populations.

Answer

Fatality of a disease.

Answer

Disease risk ratio between exposed and non-exposed.

Answer

Communicability of a disease.

Question 9

Which of the following is the primary epidemiological indicator for malaria?

Accepted Answer

Annual parasite incidence

Answer

Annual falciparum incidence

Answer

Annual blood examination rate

Answer

Annual incidence of malaria cases

Question 10

What is the secondary attack rate in a household with 9 susceptible individuals, where 1 individual becomes infected initially and 2 additional individuals become infected 2 days later?

Accepted Answer

25%

Answer

50%

Answer

65%

Answer

33%

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?